North America Plasma Fractionation Market to 2032
Overview
The North America Plasma Fractionation Market is expected to reach a 26,993.71 USD Billion by 2032 and is projected to grow at a CAGR of 10.67% from 2025 to 2032.
North America Plasma Fractionation Market 2018-2032 USD Billion
North America Plasma Fractionation Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 15,857.90 USD Billion
- Projected Market Size (2032): 26,993.71 USD Billion
- CAGR (2025-2032): 10.67%
Key Findings of North America Plasma Fractionation Market
- The North America Plasma Fractionation Market was valued at 15,857.90 USD Billion in 2024.
- The North America Plasma Fractionation Market is likely to grow at a CAGR of 10.67% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Mordern Plasma Fractionation in Mode Segment accounted for the largest share of the market with a revenue of 11,390.99 USD Billion
- The fastest growing segment Immunology in Application Segment grew Fastest with a CAGR of 12.50% during the forecast period from 2024 to 2032.
North America Plasma Fractionation Market Scope
- Protease Inhibitors
- Other Products
- Albumin
- Coagulation Factor Concentrates
- Immunoglobulins
- Rheumatology
- Haemato-Oncology
- Pulmonology
- Neurology
- Other Applications
- Critical Care
- Haematology
- Immunology
- Cryoprecipitation
- Microfiltration
- Ultrafiltration
- Affinity Chromatography
- Ion-Exchange Chromatography
- Traditional Plasma Fractionation
- Mordern Plasma Fractionation
- Clinics
- Academic Institutes
- Others
- Clinical Research Laboratories
- Hospitals
- Others
- Third Party Distribution
- Direct Tenders
North America Plasma Fractionation Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2020 |
| Unit | Revenue in USD Billion |
| Market Value in 2024 | 15,857.90 USD Billion |
| Market Value in 2032 | 26,993.71 USD Billion |
| CAGR (2025-2032) | 10.67% |
| Historic Data | 2016-2023 |
| Market Segments Covered | Product Type,Application,Processing Technology,Mode,End User,Distribution Channel |
Regional Insights:
-
Leading Market (2024-2032): North America, leading in terms of revenue 15,857.90 USD Billion in 2024
- Key Country: U.S., leading in terms of revenue with value of 10,196.83 USD Billion in 2024.
Segments and Scope
-
North America Plasma Fractionation Market to 2032, By Product Type
- Immunoglobulins is the largest segment in North America Plasma Fractionation Market to 2032 with a revenue of 7,291.16 USD Billion in the year 2024.
- Immunoglobulins is the Fastest growing segment in North America Plasma Fractionation Market to 2032 with a Growth rate of 11.41 % in forecast period 2025-2032.
-
North America Plasma Fractionation Market to 2032, By Application
- Immunology is the largest segment in North America Plasma Fractionation Market to 2032 with a revenue of 4,385.37 USD Billion in the year 2024.
- Immunology is the Fastest growing segment in North America Plasma Fractionation Market to 2032 with a Growth rate of 12.50 % in forecast period 2025-2032.
-
North America Plasma Fractionation Market to 2032, By Processing Technology
- Ion-Exchange Chromatography is the largest segment in North America Plasma Fractionation Market to 2032 with a revenue of 4,754.63 USD Billion in the year 2024.
- Ion-Exchange Chromatography is the Fastest growing segment in North America Plasma Fractionation Market to 2032 with a Growth rate of 11.75 % in forecast period 2025-2032.
-
North America Plasma Fractionation Market to 2032, By Mode
- Mordern Plasma Fractionation is the largest segment in North America Plasma Fractionation Market to 2032 with a revenue of 11,390.99 USD Billion in the year 2024.
- Mordern Plasma Fractionation is the Fastest growing segment in North America Plasma Fractionation Market to 2032 with a Growth rate of 11.08 % in forecast period 2025-2032.
-
North America Plasma Fractionation Market to 2032, By End User
- Hospitals is the largest segment in North America Plasma Fractionation Market to 2032 with a revenue of 9,473.83 USD Billion in the year 2024.
- Hospitals is the Fastest growing segment in North America Plasma Fractionation Market to 2032 with a Growth rate of 11.14 % in forecast period 2025-2032.
-
North America Plasma Fractionation Market to 2032, By Distribution Channel
- Direct Tenders is the largest segment in North America Plasma Fractionation Market to 2032 with a revenue of 7,277.25 USD Billion in the year 2024.
- Direct Tenders is the Fastest growing segment in North America Plasma Fractionation Market to 2032 with a Growth rate of 11.95 % in forecast period 2025-2032.
North America Plasma Fractionation Market Company Share Analysis
| Company Name |
|
||
| Octapharma AG | |||
| Kedrion S.p.A | |||
| Takeda Pharmaceutical Company Limited | |||
| Bartex Inc. | |||
| Grifols, S.A. | |||
North America Plasma Fractionation Market Geographical Sales Distribution, 2018-2032 USD Billion
North America Plasma Fractionation Market Company Profiling
Industry Related Reports
Frequently Asked Questions
North America Plasma Fractionation Market Scope
- Protease Inhibitors
- Other Products
- Albumin
- Coagulation Factor Concentrates
- Immunoglobulins
- Rheumatology
- Haemato-Oncology
- Pulmonology
- Neurology
- Other Applications
- Critical Care
- Haematology
- Immunology
- Cryoprecipitation
- Microfiltration
- Ultrafiltration
- Affinity Chromatography
- Ion-Exchange Chromatography
- Traditional Plasma Fractionation
- Mordern Plasma Fractionation
- Clinics
- Academic Institutes
- Others
- Clinical Research Laboratories
- Hospitals
- Others
- Third Party Distribution
- Direct Tenders
Frequently Asked Questions
North America Plasma Fractionation Market Company Profiling
Frequently Asked Questions
CHOOSE LICENCE TYPE
- 4200.00
- 3500.00
- 2000.00
- 5500.00
- 8500.00
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.